Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To assess the compatibility of Optive with refractive surgery (PRK and LASIK) post-operatively.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1. | Other |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Optive | Drug | Optive 30ml- (in the eye) Instill one in each eye twice daily starting one week after surgery |
|
| Measure | Description | Time Frame |
|---|---|---|
| Assess compatibility | 8 months |
| Measure | Description | Time Frame |
|---|---|---|
| comfort | 8 months |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Concurrent ocular conditions or pathology that could affect patient's ability to complete study
Concurrent use of topical medications other than study medications
Use of systemic medications with ocular drying sequelae:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Loren Rude, OD | TLC | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| TLC | Fullerton | California | 92831 | United States |
Not provided
| ID | Term |
|---|---|
| D015352 | Dry Eye Syndromes |
| ID | Term |
|---|---|
| D007766 | Lacrimal Apparatus Diseases |
| D005128 | Eye Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided